## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de
Combining molecular therapeutics with radiotherapy for head and neck cancer
β Scribed by Oliver Riesterer; Luka Milas; K. Kian Ang
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 78 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Sixty -eight patients were studied prospectively with serial thyroid-stimulating hormone (TSH) levels after radiotherapy for head and neck neoplasms. Overall, 57% of the patients developed elevated TSH levels. Excluding patients with less than 2 years follow-up, 85% developed an elevated TSH. N
## Abstract ## Background The purpose of this study was to investigate the incidence of radiotherapyβinduced primary and secondary hypopituitarism. ## Methods Three hundred twelve patients treated with radiotherapy for extracranial head and neck tumors between 1964 and 2000 were evaluated. Radio
## Abstract ## Background. The purpose of this study was to evaluate the use of intraoperative electron beam radiotherapy (IORT) as an adjuvant modality in the treatment of advanced head and neck and skull base cancer. ## Methods. Between 1991 and 1996, 34 patients with squamous cell carcinoma (
## Abstract ## Background The purpose of this study was to show the investigated impact of supraomohyoidal neck dissection and modified radical neck dissection, both combined with radiotherapy, on cervical range of motion (CROM), mouth opening, swallowing, lymphedema, and shoulder function. ## Me